Related references
Note: Only part of the references are listed.Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice
Aiyun Li et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Justine M. Abais et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2
Venugopal Rajanbabu et al.
CELLULAR IMMUNOLOGY (2015)
Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life
Randhir Singh et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization
Ying-Cing Lin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells
J. R. Yaron et al.
CELL DEATH & DISEASE (2015)
Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation
Annette Ives et al.
NATURE COMMUNICATIONS (2015)
Reactive Oxygen Species in Inflammation and Tissue Injury
Manish Mittal et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1
Peter A. Keyel
CYTOKINE (2014)
Reactive oxygen species in diabetic nephropathy: friend or foe?
Tzvetanka Bondeva et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Aldose Reductase Inhibition Prevents Colon Cancer Growth by Restoring Phosphatase and Tensin Homolog Through Modulation of miR-21 and FOXO3a
Ashish Saxena et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Hye-Mi Lee et al.
DIABETES (2013)
TLR Agonists Stimulate Nlrp3-Dependent IL-1β Production Independently of the Purinergic P2X7 Receptor in Dendritic Cells and In Vivo
Yuan He et al.
JOURNAL OF IMMUNOLOGY (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways
Ke-Wu Zeng et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP
Geun-Shik Lee et al.
NATURE (2012)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Aldose reductase deficiency in mice protects from ragweed pollen extract (RWE)-induced allergic asthma
Umesh C. S. Yadav et al.
RESPIRATORY RESEARCH (2011)
Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
Xinguo Hou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
The SYK tyrosine kinase: a crucial player in diverse biological functions
Attila Mocsai et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid-Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin
Xiao-Nan Li et al.
DIABETES (2009)
The roles of TLRs, RLRs and NLRs in pathogen recognition
Taro Kawai et al.
INTERNATIONAL IMMUNOLOGY (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Malarial Hemozoin Activates the NLRP3 Inflammasome through Lyn and Syk Kinases
Marina Tiemi Shio et al.
PLOS PATHOGENS (2009)
High glucose induction of DNA-binding activity of the transcription factor NFκB in patients with diabetic nephropathy
Bingmei Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica
Catherine Dostert et al.
SCIENCE (2008)
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
V. Petrilli et al.
CELL DEATH AND DIFFERENTIATION (2007)
Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition
Kota V. Ramana et al.
CIRCULATION (2006)
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy
Wei Sun et al.
DIABETES (2006)
Calcium-activated potassium channels and the regulation of vascular tone
J Ledoux et al.
PHYSIOLOGY (2006)
Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options
SK Srivastava et al.
ENDOCRINE REVIEWS (2005)
Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells
KV Ramana et al.
DIABETES (2005)
Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes
K Green et al.
DIABETES (2004)
PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane
P Viard et al.
NATURE NEUROSCIENCE (2004)
Activation of nulcear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase
KV Ramana et al.
DIABETES (2004)
Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes
P Schrauwen et al.
DIABETES (2004)
Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats
IG Obrosova et al.
DIABETES (2003)
BTK regulates Ptdlns-4,5-P-2 synthesis: Importance for calcium signaling and PI3K activity
K Saito et al.
IMMUNITY (2003)
Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells
KV Ramana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (Fidarestat):: Its absolute configuration and interactions with the aldose reductase by X-ray crystallography
M Oka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
